Corden Pharma of Germany has entered into a technology alliance agreement with Nanos, based in South Korea, relating to the production of Peptides.

Nanos is a top supplier of camera modules for Samsung Electronics’ mobile phone business.

Due to a relocation of Samsung Electronics’ mobile business to Vietnam, Nanos’ manufacturing factory in Hwasung, Korea, remains out of production.

Through in-licensing or a large-scale direct investment, Nanos plans to transform and utilize the existing production facility to launch high value products, such as Peptides, a potential agent for cancer immunotherapy drugs.

Nanos’ partnership with CordenPharma, one of the leading global development and manufacturing organizations (CDMO), represents Nanos’ strategic intention to establish long-term production and sale of therapeutic drugs involving Peptides, which are currently in Phase 2 clinical trials.